Alexandra Botie | Crescendo Communications, LLC |
Jan D’Alvise | President and CEO |
Pierre Lemieux | COO, Chief Scientific Officer and Co-Founder |
Brian Groch | Chief Commercial Officer |
Jean-François Boily | VP, Finance |
Leland Gershell | Oppenheimer & Co. |
Mayank Mamtani | B. Riley FBR, Inc. |
Andre Uddin | Mackie Research Capital Corporation |
Nathan Weinstein | Aegis Capital |
Good day, ladies and gentlemen, and welcome to Acasti Pharma Fiscal Year 2020 Business Update Conference Call. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host Alexandra Botie, Investor Relations. Ma'am, the floor is yours.
Thank you. Good afternoon, everyone, and welcome to Acasti Pharma's fourth quarter and year-end fiscal 2020 conference call.